InsiderTrades.com logo

FATE Insider Trading

Insider Ownership Percentage: 5.51%
Insider Buying (Last 12 Months): $668,579.52
Insider Selling (Last 12 Months): $47,587.88

Fate Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Fate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fate Therapeutics Share Price & Price History

Current Price: $1.10
Price Change: ▲ Price Increase of +0.02 (1.85%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for FATE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fate Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/4/2025Bahram ValamehrCEOSell14,466$1.06$15,333.96334,898View SEC Filing Icon  
8/4/2025Cindy TahlInsiderSell9,037$1.06$9,579.22397,670View SEC Filing Icon  
1/10/2025Bahram ValamehrCEOSell8,705$1.54$13,405.70349,364View SEC Filing Icon  
1/10/2025Jerome Charles BressiInsiderSell5,980$1.55$9,269.00270,203View SEC Filing Icon  
12/20/2024Redmile Group, LlcDirectorBuy397,964$1.68$668,579.5212,884,277View SEC Filing Icon  
8/6/2024Yuan XuDirectorSell633$4.23$2,677.598,669View SEC Filing Icon  
1/29/2024Edward J. Dulac, IIICFOSell1,849$5.00$9,245.00103,926View SEC Filing Icon  
1/9/2024Bahram ValamehrInsiderSell11,271$4.38$49,366.98158,069View SEC Filing Icon  
1/9/2024Cindy TahlGeneral CounselSell10,874$4.37$47,519.38142,361View SEC Filing Icon  
1/9/2024Edward J. Dulac, IIICFOSell7,028$4.37$30,712.36105,775View SEC Filing Icon  
1/9/2024J. Scott WolchkoCEOSell14,391$4.37$62,888.67371,248View SEC Filing Icon  
12/26/2023Redmile Group, LlcDirectorBuy44,630$3.72$166,023.6013,180,388View SEC Filing Icon  
8/18/2023Edward J. Dulac, IIICFOSell4,718$2.80$13,210.40119,570View SEC Filing Icon  
8/4/2023Yuan XuDirectorSell632$3.71$2,344.729,302View SEC Filing Icon  
7/5/2023Brian T PowlInsiderSell3,854$4.87$18,768.9841,146View SEC Filing Icon  
7/5/2023Edward J. Dulac, IIICFOSell5,182$4.83$25,029.06124,288View SEC Filing Icon  
6/14/2023Yuan XuDirectorSell3,460$5.58$19,306.809,934View SEC Filing Icon  
4/20/2023Redmile Group, LlcDirectorBuy20,000$5.99$119,800.0012,879,119View SEC Filing Icon  
4/18/2023Yu-Waye ChuInsiderSell2,532$6.57$16,635.24140,676View SEC Filing Icon  
4/14/2023Redmile Group, LlcDirectorBuy25,700$6.00$154,200.0012,859,119View SEC Filing Icon  
1/13/2023John MendleinDirectorBuy36,631$5.43$198,906.33282,770View SEC Filing Icon  
1/11/2023John MendleinDirectorBuy88,048$5.67$499,232.16246,139View SEC Filing Icon  
1/10/2023Bahram ValamehrInsiderSell10,917$5.24$57,205.08168,917View SEC Filing Icon  
1/10/2023Cindy TahlGeneral CounselSell11,553$5.24$60,537.72177,598View SEC Filing Icon  
1/10/2023Edward J. Dulac, IIICFOSell7,331$5.24$38,414.44129,470View SEC Filing Icon  
1/10/2023J. Scott WolchkoCEOSell45,907$5.24$240,552.68385,639View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FATE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Fate Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.814,639$1.03M0.0%-32.9%0.706%Search for SEC Filing on Google Icon
11/17/2025Susquehanna International Group LLP178,927$0.23M0.0%-53.8%0.155%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC963,871$1.21M0.0%+9.6%0.836%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE146,553$0.19M0.0%+20.0%0.127%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC106,920$0.14M0.0%N/A0.093%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.261,671$0.33M0.0%-23.0%0.227%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC544,587$0.69M0.0%-41.5%0.472%Search for SEC Filing on Google Icon
11/14/2025Man Group plc219,658$0.28M0.0%N/A0.190%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP900,757$1.14M0.0%+294.4%0.781%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC100,000$0.13M0.0%+300.0%0.087%Search for SEC Filing on Google Icon
11/13/2025Bruce & Co. Inc.729,188$0.92M0.3%+69.9%0.632%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets27,356$34K0.0%-90.5%0.024%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.28,676$36K0.0%+73.1%0.025%Search for SEC Filing on Google Icon
11/13/2025Knott David M Jr365,000$0.46M0.2%N/A0.316%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,094,975$2.64M0.0%-14.1%1.817%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC56,316$71K0.0%-23.3%0.049%Search for SEC Filing on Google Icon
11/10/2025Monaco Asset Management SAM770,000$0.97M0.1%+14.1%0.668%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP310,826$0.39M0.0%+21.1%0.270%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.8,798,491$11.09M0.0%+0.4%7.629%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC35,968$45K0.0%+48.6%0.031%Search for SEC Filing on Google Icon
11/4/2025Privium Fund Management B.V.333,219$0.42M0.1%+200.0%0.289%Search for SEC Filing on Google Icon
10/15/2025CWM LLC66,093$83K0.0%+33.7%0.057%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC22,502$28K0.0%-30.0%0.020%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.145,838$0.18M0.0%-31.3%0.126%Search for SEC Filing on Google Icon
8/26/2025Thrivent Financial for Lutherans37,116$41K0.0%-58.4%0.032%Search for SEC Filing on Google Icon
8/16/2025Headlands Technologies LLC49,556$56K0.0%N/A0.043%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets287,412$0.32M0.0%-16.0%0.249%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC25,000$28K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/15/2025Bruce & Co. Inc.429,188$0.48M0.2%-22.0%0.372%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE122,130$0.14M0.0%-68.6%0.106%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.339,714$0.38M0.0%-17.4%0.295%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC465,820$0.52M0.0%+631.4%0.406%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.67,721$76K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.255,372$0.29M0.0%+19.6%0.223%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd432,328$0.48M0.0%-5.9%0.377%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.58,574$66K0.0%-98.3%0.051%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC2,429,167$2.72M0.0%+7.0%2.120%Search for SEC Filing on Google Icon
8/7/2025Monaco Asset Management SAM675,000$0.76M0.1%-41.3%0.589%Search for SEC Filing on Google Icon
8/7/2025Acadian Asset Management LLC2,459,954$2.75M0.0%-0.6%2.147%Search for SEC Filing on Google Icon
8/6/2025Savant Capital LLC24,205$27K0.0%N/A0.021%Search for SEC Filing on Google Icon
7/25/2025Vanguard Personalized Indexing Management LLC71,364$80K0.0%+65.6%0.062%Search for SEC Filing on Google Icon
7/15/2025Public Employees Retirement System of Ohio113,655$0.13M0.0%-30.1%0.099%Search for SEC Filing on Google Icon
7/11/2025Assenagon Asset Management S.A.212,342$0.24M0.0%-29.9%0.185%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers150,248$0.12M0.0%-5.6%0.131%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC2,473,565$1.95M0.0%+67.8%2.158%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC63,691$50K0.0%+106.9%0.056%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.2,458,974$1.94M0.0%-0.7%2.146%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.2,203,323$1.74M0.0%+38.8%1.923%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC585,025$0.46M0.0%+296.4%0.510%Search for SEC Filing on Google Icon
5/15/2025Vestal Point Capital LP2,515,850$1.99M0.1%+2.1%2.195%Search for SEC Filing on Google Icon
5/15/2025Caption Management LLC57,000$45K0.0%N/A0.050%Search for SEC Filing on Google Icon
5/14/2025Comerica Bank82,024$65K0.0%+55,698.6%0.072%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC72,286$57K0.0%-93.3%0.063%Search for SEC Filing on Google Icon
5/14/2025Bruce & Co. Inc.550,000$0.43M0.1%+57.1%0.480%Search for SEC Filing on Google Icon
5/13/2025Russell Investments Group Ltd.79,377$63K0.0%-11.6%0.069%Search for SEC Filing on Google Icon
5/13/2025Callan Family Office LLC82,024$65K0.0%N/A0.072%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC379,088$0.30M0.0%N/A0.331%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.213,503$0.17M0.0%+96.0%0.186%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.703,825$0.56M0.0%-8.6%0.614%Search for SEC Filing on Google Icon
5/9/2025Privium Fund Management B.V.109,026$86K0.0%+25.3%0.095%Search for SEC Filing on Google Icon
5/8/2025Monaco Asset Management SAM1,149,708$0.91M0.2%+250.9%1.003%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd459,308$0.36M0.0%+83.9%0.401%Search for SEC Filing on Google Icon
5/1/2025CWM LLC41,435$33K0.0%+899.6%0.036%Search for SEC Filing on Google Icon
4/17/2025Exchange Traded Concepts LLC131,830$0.10M0.0%+211.7%0.115%Search for SEC Filing on Google Icon
4/15/2025Assenagon Asset Management S.A.302,899$0.24M0.0%-18.7%0.264%Search for SEC Filing on Google Icon
2/19/2025Public Employees Retirement System of Ohio88,766$0.15M0.0%-34.2%0.078%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP1,422,785$2.35M0.0%-53.6%1.249%Search for SEC Filing on Google Icon
2/17/2025Vestal Point Capital LP2,465,000$4.07M0.2%+46.3%2.164%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC34,295$57K0.0%+154.2%0.030%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP297,106$0.49M0.0%-35.4%0.261%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP828,100$1.37M0.0%-10.7%0.727%Search for SEC Filing on Google Icon
2/17/2025Tang Capital Management LLC1,855,954$3.06M0.2%+165.1%1.630%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.397,177$0.66M0.1%N/A0.349%Search for SEC Filing on Google Icon
2/17/2025Redmile Group LLC12,872,946$21.24M1.5%-2.2%11.303%Search for SEC Filing on Google Icon
2/17/2025Point72 Asia Singapore Pte. Ltd.33,094$55K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC33,645$56K0.0%+77.9%0.030%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC413,192$0.68M0.0%+28.9%0.363%Search for SEC Filing on Google Icon
2/17/2025Integral Health Asset Management LLC600,000$0.99M0.1%-38.5%0.527%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.22,342$37K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.1,536,633$2.54M0.0%-54.5%1.349%Search for SEC Filing on Google Icon
2/17/2025Brevan Howard Capital Management LP24,636$41K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/17/2025Baker BROS. Advisors LP3,258,402$5.38M0.1%+8.7%2.861%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE304,129$0.50M0.0%-64.4%0.267%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets287,711$0.48M0.0%+65.2%0.253%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.177,161$0.29M0.0%-29.1%0.156%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC30,780$51K0.0%-79.2%0.027%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp805,518$1.33M0.0%-1.2%0.707%Search for SEC Filing on Google Icon
2/14/2025Susquehanna Fundamental Investments LLC118,186$0.20M0.0%N/A0.104%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD38,049$63K0.0%-41.7%0.033%Search for SEC Filing on Google Icon
2/14/2025Dark Forest Capital Management LP61,220$0.10M0.0%+128.0%0.054%Search for SEC Filing on Google Icon
2/14/2025Hsbc Holdings PLC109,422$0.18M0.0%+22.0%0.096%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC16,641$27K0.0%-61.0%0.015%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP2,898,377$4.78M0.0%+10.7%2.545%Search for SEC Filing on Google Icon
2/13/2025CANADA LIFE ASSURANCE Co21,267$35K0.0%-53.4%0.019%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP512,641$0.85M0.0%N/A0.450%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC1,083,092$1.79M0.0%+1,502.0%0.951%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd249,800$0.41M0.0%N/A0.219%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC378,619$0.63M0.0%+4.4%0.332%Search for SEC Filing on Google Icon
2/13/2025Cerity Partners LLC823,134$1.36M0.0%+4,953.6%0.723%Search for SEC Filing on Google Icon
2/13/2025Federated Hermes Inc.543,021$0.90M0.0%-1.8%0.477%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Fate Therapeutics logo
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Read More on Fate Therapeutics

Today's Range

Now: $1.10
Low: $1.05
High: $1.12

50 Day Range

MA: $1.25
Low: $0.96
High: $1.65

52 Week Range

Now: $1.10
Low: $0.66
High: $2.93

Volume

1,414,050 shs

Average Volume

1,331,115 shs

Market Capitalization

$126.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.34

Who are the company insiders with the largest holdings of Fate Therapeutics?

Fate Therapeutics' top insider investors include:
  1. Redmile Group, Llc (Director)
  2. Cindy Tahl (Insider)
  3. J Scott Wolchko (CEO)
  4. Bahram Valamehr (CEO)
  5. Jerome Charles Bressi (Insider)
  6. Bahram Valamehr (Insider)
  7. Cindy Tahl (General Counsel)
  8. Edward J Dulac III (CFO)
  9. Yuan Xu (Director)
Learn More about top insider investors at Fate Therapeutics.

Who are the major institutional investors of Fate Therapeutics?

Fate Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 7.63%
  2. Dimensional Fund Advisors LP — 1.82%
  3. Millennium Management LLC — 0.84%
  4. Two Sigma Investments LP — 0.78%
  5. Jacobs Levy Equity Management Inc. — 0.71%
  6. Monaco Asset Management SAM — 0.67%
Learn More about top institutional investors of Fate Therapeutics stock.

Which institutional investors are selling Fate Therapeutics stock?

Within the previous quarter, FATE stock was sold by these institutional investors:
  1. Jacobs Levy Equity Management Inc.
  2. Schonfeld Strategic Advisors LLC
  3. Dimensional Fund Advisors LP
  4. BNP Paribas Financial Markets
  5. Susquehanna International Group LLP
  6. Ameriprise Financial Inc.
  7. Assenagon Asset Management S.A.
  8. Intech Investment Management LLC
In the last year, company insiders that have sold Fate Therapeutics company stock include:
  1. Redmile Group, Llc (Director)
  2. Cindy Tahl (Insider)
  3. J Scott Wolchko (CEO)
Learn More investors selling Fate Therapeutics stock.

Which institutional investors are buying Fate Therapeutics stock?

During the previous quarter, FATE stock was acquired by institutional investors including:
  1. Two Sigma Investments LP
  2. Knott David M Jr
  3. Bruce & Co. Inc.
  4. Privium Fund Management B.V.
  5. Man Group plc
  6. Algert Global LLC
  7. Monaco Asset Management SAM
  8. Millennium Management LLC